Eli Lilly’s ulcerative colitis (UC) treatment, Omvoh (mirikizumab), has shown sustained positive outcomes in patients with ...

The second phase of Precision Oncology Ireland (POI), the country’s largest cancer research programme has been launched by ...

As a young brand manager, an ancient account director interrupted my unclear verbal brief to demand two things. First, he ...

Among the key developments is a move towards greater regulatory alignment between the two agencies. Under the MHRA’s proposed ...

Eli Lilly has appointed Peter Marks, former director of the US Food and Drug Administration’s (FDA) Centre for Biologics ...

When they feel safe to speak up, organisations gain access to real-time insights that can help deliver valuable change. For ...

Epsilogen, a UK-based biotech developing pan-isotype antibody therapies for use in cancer treatment, has appointed Cristina ...

Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based ...

We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our ...

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications ...

Launching a biopharmaceutical product globally always involves significant uncertainty – especially before pivotal clinical ...

Pfizer’s Lorviqua (lorlatinib) has been recommended by the National Institute for Health and Care Excellence (NICE) as a ...